Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy

Adv Neurol. 1993:60:438-46.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antidepressive Agents / therapeutic use*
  • Antiparkinson Agents / therapeutic use
  • Catecholamines / metabolism*
  • Dementia / drug therapy
  • Dementia / pathology*
  • Dementia / psychology
  • Depressive Disorder / drug therapy
  • Depressive Disorder / pathology*
  • Depressive Disorder / psychology
  • Drug Therapy, Combination
  • Female
  • Humans
  • Locus Coeruleus / drug effects
  • Locus Coeruleus / pathology*
  • Male
  • Middle Aged
  • Monoamine Oxidase Inhibitors / therapeutic use*
  • Neurons / pathology
  • Neuropsychological Tests
  • Norepinephrine / metabolism
  • Parkinson Disease / drug therapy
  • Parkinson Disease / pathology*
  • Parkinson Disease / psychology
  • Tyrosine 3-Monooxygenase / physiology

Substances

  • Antidepressive Agents
  • Antiparkinson Agents
  • Catecholamines
  • Monoamine Oxidase Inhibitors
  • Tyrosine 3-Monooxygenase
  • Norepinephrine